Core Insights - The company has successfully delivered adjustable insulin injection pens to international clients in bulk, with a smooth supply chain [1] - The company has signed orders for weight loss pens, and the automated production line for these products is under construction, expected to be operational next year [1] - The company possesses three mature technology platforms: adjustable pens, energy storage pens, and PFS pens, enabling full-chain independent production capabilities from mold development to automated assembly [1] - To enhance the development of the injection pen business, the company has established an independent division and is actively expanding its customer base through various channels, including domestic and international exhibitions [1]
美好医疗：公司为国际客户定制的可调式胰岛素注射笔已实现批量交付